Medicenna Announces Formation of its Scientific Advisory Board
TORONTO and HOUSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA TSX: MDNA),...
News
Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA
ACTON, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics...
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Development of VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
- VRDN-002 incorporates clinically validated half-life extension technology to support development as a low volume subcutaneous injection -- Company expects...
Akouos to Participate in Upcoming February Virtual Investor Conferences
BOSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing...
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for Hepatic Ballooning in Canada
LA JOLLA, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
HEXO Provides Nasdaq Listing Update
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 11, 2021...
R1 Earns Top Score in Human Rights Campaign’s 2022 Corporate Equality Index
R1 received 100% ranking and was named one of the Best Places to Work for LGBTQ+ EqualityMURRAY, Utah, Jan. 31,...
Fennec Pharmaceuticals Announces Management Change
RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company...
Ocuphire Presenting New Data and Updates on APX3330 and Nyxol® Clinical Programs at Virtual Investor R&D Day
New data support Phase 3 development of Nyxol alone as a durable single eye drop for the potential treatment of...
Bloom Health Partners Reports Profitable Fiscal Year 2021 with $9.8 Million in Revenue
Results show a strong first fiscal year, with $5.5 million in cash and continued growth from operationsVancouver, British Columbia--(Newsfile Corp....
CENTR Launches in Leading National Wine Superstore
Vancouver, British Columbia--(Newsfile Corp. - January 31, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Therma Bright Completes U.S. Clinical Performance Study Subject Recruitment
Toronto, Ontario--(Newsfile Corp. - January 31, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
Philips Earns Top Score of 100 in Human Rights Campaign Foundation’s Annual Assessment of LGBTQ+ Workplace Equality
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it received a...
Promore Pharma Deregisters Warrants
STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 31 January 2022 - Promore Pharma announces today...
Relief Therapeutics Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA
GENEVA, SWITZERLAND / ACCESSWIRE / January 31, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
CORRECTION FROM SOURCE: CENTR Brands Corp. Announces Q2 2022 Results
While presented correctly in its Financial Statements and MD&A as filed on SEDAR, the date of the ending of Q2...
Mountain Valley MD Holdings Announces Restricted Share Unit Plan, RSU Grant and Stock Option Grant
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)...
Vimian Group Acquires Leading Companion Animal Health Specialty Pharmaceuticals Company in the UK
STOCKHOLM, SE / ACCESSWIRE / January 28, 2022 / Vimian Group (STO:VIMIAN)Vimian Group has today signed an agreement to acquire...
CENTR Brands Corp. Announces Q2 2022 Results
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Psyched Wellness Implements RSU Plan and Grant RSUS
Toronto, Ontario--(Newsfile Corp. - January 28, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...